Dan Kemp, Shinobi Therapeutics CEO
Japanese government grants Shinobi $59M for cell therapy development
Cell therapy biotech Shinobi Therapeutics has pulled in $59 million in funding from a Japanese government grant. The pharma company also expanded its Series A …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.